Inventor · disambiguated record
Mark W. Holladay
Also filed as: HOLLADAY MARK · HOLLADAY MARK W
43 granted patents·9 pending applications·923 citations·filing 1991–2017
98Inventor score
Files withABBOTT LAB19AMBIT BIOSCIENCES CORP16XENON PHARMACEUTICALS INC5HADD MICHAEL J3HOLLADAY MARK W2
Top patents by PatentIndex Score
52 records- 0196US5346907AAmino acid analog CCK antagonistsABBOTT LAB·Filed 1993·Granted Sep 13, 1994·94 cites·6 claims
- 0294US8030488B2Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Oct 4, 2011·34 cites·28 claims
- 0394US5948793A3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter releaseABBOTT LAB·Filed 1995·Granted Sep 7, 1999·77 cites·8 claims
- 0492US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0592US6437138B13-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 2000·Granted Aug 20, 2002·54 cites·2 claims
- 0692US5629325A3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1996·Granted May 13, 1997·106 cites·9 claims
- 0791US10829484B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 10, 2020·5 cites·21 claims
- 0891US5914328AHeterocyclic ether compounds useful in controlling neurotransmitter releaseABBOTT LAB·Filed 1995·Granted Jun 22, 1999·67 cites·31 claims
- 0990US8618289B2RAF kinase modulator compounds and methods of use thereofABRAHAM SUNNY·Filed 2009·Granted Dec 31, 2013·22 cites·26 claims
- 1089US9320739B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Granted Apr 26, 2016·6 cites·11 claims
- 1188US8969587B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2013·Granted Mar 3, 2015·8 cites·14 claims
- 1286US8703943B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofHOLLADAY MARK W·Filed 2011·Granted Apr 22, 2014·7 cites·19 claims
- 1386US8349851B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 8, 2013·9 cites·19 claims
- 1486US7456180B2Piperazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·24 cites·25 claims
- 1585US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 1683US6265417B1Potassium channel openersABBOTT LAB·Filed 1998·Granted Jul 24, 2001·30 cites·13 claims
- 1782US7749980B2Non-nucleotide compositions and method for treating painINSPIRE PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·22 cites·20 claims
- 1880US6127386A3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Oct 3, 2000·47 cites·13 claims
- 1979US5472958A2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive functionABBOTT LAB·Filed 1994·Granted Dec 5, 1995·55 cites·3 claims
- 2078US10053430B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2017·Granted Aug 21, 2018·1 cites·2 claims
- 2177US9725465B2Biaryl acetamide compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Aug 8, 2017·3 cites·4 claims
- 2277US5340802APeptide analog type-B CCK receptor ligandsABBOTT LAB·Filed 1993·Granted Aug 23, 1994·47 cites·11 claims
- 2375US9730937B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Aug 15, 2017·1 cites·19 claims
- 2475US8927711B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Jan 6, 2015·2 cites·19 claims
- 2575US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 2673US6403575B13-Pyridyl enantiomers and their use as analgesicsABBOTT LAB·Filed 2000·Granted Jun 11, 2002·3 cites·4 claims
- 2772US9452167B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Sep 27, 2016·1 cites·20 claims
- 2872US8912324B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofHOLLADAY MARK W·Filed 2011·Granted Dec 16, 2014·1 cites·19 claims
- 2972US5733912A7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Mar 31, 1998·35 cites·7 claims
- 3069US6645968B2Potassium channel openersABBOTT LAB·Filed 2001·Granted Nov 11, 2003·5 cites·78 claims
- 3168US6593335B1Potassium channel openersABBOTT LAB·Filed 1999·Granted Jul 15, 2003·28 cites·54 claims
- 3268US6538000B1Tricyclic dihydropyrimidine potassium channel openersABBOTT LAB·Filed 2000·Granted Mar 25, 2003·4 cites·55 claims
- 3366US9295672B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 29, 2016·0 cites·23 claims
- 3466US8952020B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Feb 10, 2015·0 cites·24 claims
- 3563US5270302ADerivatives of tetrapeptides as CCK agonistsABBOTT LAB·Filed 1991·Granted Dec 14, 1993·23 cites·10 claims
- 3660US6274587B1Tricyclic dihydropyrimidine potassium channel openersABBOTT LAB·Filed 1999·Granted Aug 14, 2001·8 cites·57 claims
- 3759US9308207B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Apr 12, 2016·0 cites·19 claims
- 3855US8952058B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Feb 10, 2015·0 cites·13 claims
- 3953US2015353528A1Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Application pending·0 cites
- 4052US9938261B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Apr 10, 2018·0 cites·23 claims
- 4151US6133253A3-Pyridyl enantiomers and their use as analgesicsABBOTT LAB·Filed 1997·Granted Oct 17, 2000·12 cites·6 claims
- 4251US2011269740A1Jak kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2009·Application pending·0 cites
- 4345US6503935B1Imidazoles and related compounds as α1A agonistsABBOTT LAB·Filed 1999·Granted Jan 7, 2003·5 cites·6 claims
- 4444US6001849AFuropyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmissionABBOTT LAB·Filed 1997·Granted Dec 14, 1999·6 cites·14 claims
- 4540US2013303533A1Azolopyridine and azolopyrimidine compounds and methods of use thereofCHAO QI·Filed 2011·Application pending·0 cites
- 4639US2001036950A1Potassium channel openersFiled 2001·Application pending·0 cites
- 4738US2013296363A1Quinoline and isoquinoline derivatives for use as jak modulatorsFARAONI RAFFAELLA·Filed 2011·Application pending·0 cites
- 4837US2013035326A1Biaryl compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Application pending·0 cites
- 4935US2012053176A1Adenosine a3 receptor modulating compounds and methods of use thereofARMSTRONG ROBERT C·Filed 2011·Application pending·0 cites
- 5032US8633207B2Quinazoline compounds and methods of use thereofHADD MICHAEL J·Filed 2011·Granted Jan 21, 2014·0 cites·18 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →